<DOC>
	<DOCNO>NCT00505063</DOCNO>
	<brief_summary>This study look body 's response new immunization . We want see well protect . Immunization vaccination . Our goal protect much . We want measles , mumps , whooping cough . We study standard way re-immunize people cancer treatment .</brief_summary>
	<brief_title>Prospective Trial Vaccine Responses Childhood Cancer Survivors</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Patient must &lt; less 18 year age cancer diagnosis Patient must 3 24months follow completion chemotherapy malignant disease . 1 . For patient &lt; 12 month follow completion therapy , CR must document within 3 month enrollment . 2 . For patient &gt; 12 month , CR must document approximately 12 month clinically indicate . For patient leukemia : bone marrow aspirate define &lt; 5 % blast , absence cytogenetic abnormality FISH karyotype ( applicable ) evidence CSF involvement ( applicable ) ii . For patient solid tumor remission determine appropriate radiologic scan , test , include bone marrow aspirate biopsy demonstrate absence extrinsic cell absence specific FISH cytogenetic abnormality ( applicable ) , iii . For patient lymphoma , remission determine bone marrow aspirate biopsy , radiologic scan test . Bone marrow show &lt; 5 % blast , absence cytogenetic abnormality FISH karyotype ( applicable ) , flow cytometry ( lymphoma specific marker present ) absence CNS disease spinal fluid ( applicable ) Patient may either gender ethnic background Patients guardian must able understand nature risk propose study able sign consent . Karnofsky score &lt; 70 % . Female patient pregnant lactate . Patients receive autologous allogeneic HCT . Active uncontrolled bacterial fungal infection . Patients history previous allergic reaction vaccination currently recommend ACIP . Patients immunosuppressive drug . HIV1,2 seropositive patient . Patients guardian sign informed consent . Patients prior allergic reaction vaccine component latex . Patients receive Rituximab .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>vaccine</keyword>
	<keyword>childhood</keyword>
	<keyword>cancer</keyword>
</DOC>